ImmuniT Research Inc. selected as one of the top 3 award-winning companies in the KLSAP acceleration program.
ImmuniT Research inc. was selected as one of the top 3 winning companies in the accelerator program of the KLSAP (Kansai Life Science Accelerator Program), which specializes in bio-venture startups, held on July 14, 2023 by the Kobe Biomedical Innovation Promotion Organization. As a result, we have acquired the right to participate in the accelerator program that can receive various support from investors and entrepreneurs in California, USA by California Life Sciences (CLS), which specializes in bio-startups.